COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

January 16, 2022
Preprint
Open Access

Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance

MedRxiv : the Preprint Server for Health Sciences
S. NasreenJeffrey C. Kwong
January 16, 2022

Complement activation induces excessive T cell cytotoxicity in severe COVID-19.

Cell
Philipp GeorgPA-COVID-19 Study Group
January 16, 2022
Review

Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.

International Immunopharmacology
Hayder M Al-KuraishyGaber El-Saber Batiha
January 16, 2022
Review

Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy.

Clinical Reviews in Allergy & Immunology
Zhangkai J ChengBaoqing Sun
January 15, 2022

Molecular Mechanism of -Acute Sarcopenia in Elderly Patient with COVID - 19.

Acta Medica Indonesiana
I Gusti Putu Suka AryanaSandra Surya Rini
January 15, 2022

Herpes Zoster After Tocilizumab Therapy in COVID-19 Survivor: A Case Report.

Acta Medica Indonesiana
Suwenny Suwenny, Sahat Halim
January 15, 2022
Case Report

Dengue Versus Multisystem Inflammatory Syndrome - When the Grey Zone Gets Thinner.

Curēus
Aneesh BasheerManish Murali
January 15, 2022
Review

Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?

Molecular Neurobiology
Theoharis C Theoharides
January 15, 2022

The impact of COVID-19 vaccination on patients with a history of heparin induced thrombocytopenia.

British Journal of Haematology
U FaruqiK Breen
January 14, 2022

COVID-19 associated with immune thrombocytopenia: a systematic review and meta-analysis.

Expert Review of Hematology
Mohammed Ghannam Alharbi
January 13, 2022
Preprint
Open Access

A unique dexamethasone-dependent gene expression profile in the lungs of COVID-19 patients

MedRxiv : the Preprint Server for Health Sciences
U. FahnoeR. R. Plovsing
January 14, 2022

Arterial intracranial thrombosis as the first manifestation of vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Michelangelo MancusoMirco Cosottini

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Cardiovascular Complications

Growing evidence shows that COVID-19 can result in serious complications affecting the cardiovascular system, including dysrhythmias, myocarditis, acute myocardial infarction, and heart failure. This feed follows studies investigating the effects of SARS-CoV-2 infection on the heart.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

© 2022 Meta ULC. All rights reserved
/feed-previews/covid-19-immunopathology/718c2c4e-a9c3-40c6-b6e9-5bab37fa1658